Moreover, a highly significant HR for death does not necessarily mean that a prognostic signature or biomarker will be of clinical utility, since it does not imply that the predictive accuracy of the marker is sufficient to justify its use in clinical practice.
← all excerpts
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.
1
—
—